- Acheter crypto
- Marchés
- Futures
- Spot
- Copy trading
WE-Launch
Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity extension company and has been receiving regular intravenous stem cell infusion therapy over the past year.
BlockBeats News, August 21st. According to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human life extension. He recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly flown to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." While the company's name was not disclosed due to ongoing rebranding, he emphasized: "This is a future trend - an increasing number of countries are relaxing regulations on stem cell usage."
Vous pourriez aussi aimer
À la hausse
Dernières actus crypto
WSJ: Les investisseurs se méfient d'un nouveau cycle du "Crypto Winter"
Aethir publie une feuille de route sur 12 mois pour accélérer la croissance de l'entreprise mondiale de l'IA
Financement ponctuel sur 24 heures Liste des entrées/sorties : Sortie nette des EPF de 126 millions de dollars, sortie nette des ZEC de 18,2 millions de dollars
Bloomberg: La Fed n'a jamais été aussi divisée sur la stratégie de taux longs
Données clés sur les transactions : Le rendement des bons du Trésor américain à 10 ans monte à 4,086%
Assistance client：@weikecs
Collaborations commerciales：@weikecs
Trading quantitatif/Market makers：[email protected]
Programme VIP：[email protected]
App